Related Articles
Marked tumor response to crizotinib after 4 years of maintenance pemetrexed in a patient with anaplastic lymphoma kinase‑positive non‑small‑cell lung cancer
EML4-ALK translocation is associated with early onset of disease and other clinicopathological features in Chinese female never-smokers with non-small-cell lung cancer
Anaplastic lymphoma kinase‑positive squamous cell carcinoma of the lung: A case report
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
A case of lung adenocarcinoma with a concurrent EGFR mutation and ALK rearrangement: A case report and literature review